These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 7329931)
1. Treatment of fungal infections. Hay RJ Practitioner; 1981 Oct; 225(1360):1413-8. PubMed ID: 7329931 [No Abstract] [Full Text] [Related]
2. Drugs for treatment of systemic fungal infections. Med Lett Drugs Ther; 1984 Mar; 26(658):36-8. PubMed ID: 6321929 [No Abstract] [Full Text] [Related]
3. Drugs for treatment of deep fungal infection. Med Lett Drugs Ther; 1988 Mar; 30(761):30-2. PubMed ID: 3343965 [No Abstract] [Full Text] [Related]
4. Liposomal amphotericin B for the treatment of severe fungal infection. Michaud D Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230 [TBL] [Abstract][Full Text] [Related]
5. Treatment of fungal infections of the central nervous system. Bell WE Ann Neurol; 1981 May; 9(5):417-22. PubMed ID: 7023352 [TBL] [Abstract][Full Text] [Related]
6. Topical and systemic antifungal agents. Bodey GP Med Clin North Am; 1988 May; 72(3):637-59. PubMed ID: 3280911 [TBL] [Abstract][Full Text] [Related]
7. Continuous infusion of amphotericin B deoxycholate: a cost-effective gold standard for therapy of invasive fungal infections? Schneemann M; Bachli EB Clin Infect Dis; 2004 Jan; 38(2):303-4; author reply 306-7. PubMed ID: 14699468 [No Abstract] [Full Text] [Related]
10. Systemic antifungal drugs. Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113 [No Abstract] [Full Text] [Related]
11. [Amphotericin B: the end of an era]. Oude Lashof AM; Kullberg BJ Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116 [TBL] [Abstract][Full Text] [Related]
12. [New aspects in treatment of systemic mycoses]. Presterl E; Graninger W Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965 [TBL] [Abstract][Full Text] [Related]
14. [Therapy of human mycoses. Drugs for systemic and topical treatment of fungal infections]. Raab W Berl Munch Tierarztl Wochenschr; 1980 Sep; 93(17-18):335-41. PubMed ID: 7008770 [No Abstract] [Full Text] [Related]
15. Implementation of clinical practice policy on the continuous intravenous administration of amphotericin B deoxycholate. Maharom P; Thamlikitkul V J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S118-24. PubMed ID: 17718252 [TBL] [Abstract][Full Text] [Related]
16. Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes. Garbino J; Markham L; Matulionyte R; Rives V; Lew D Scand J Infect Dis; 2006; 38(2):110-3. PubMed ID: 16449001 [TBL] [Abstract][Full Text] [Related]
17. Focus on fungal infections. MacDougall DS J Int Assoc Physicians AIDS Care; 1997 Jul; 3(7):27-32. PubMed ID: 11364470 [TBL] [Abstract][Full Text] [Related]
18. Lipid formulations of amphotericin B. Dix SP; Andriole VT Curr Clin Top Infect Dis; 2000; 20():1-23. PubMed ID: 10943516 [TBL] [Abstract][Full Text] [Related]
19. [Choice and use of antifungal drugs]. Dupont B Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672 [TBL] [Abstract][Full Text] [Related]
20. Liposome battle for antifungal market shifts into high gear. Marks S J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):46-7. PubMed ID: 11363518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]